AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$4.89

Daily low

$4.76

Price at open

$4.79

52 Week High

$6.45

52 Week Low

$2.78

Market cap

389.7M

Dividend yield

0.00%

Volume

77,088

Avg. volume

366,811

P/E ratio

-2.29

Atea Pharmaceuticals News